Enhabit, Inc. (EHAB)
NYSE: EHAB · Real-Time Price · USD
7.88
+0.02 (0.19%)
Dec 3, 2024, 2:07 PM EST - Market open
Enhabit Market Cap
Enhabit has a market cap or net worth of $395.99 million as of December 3, 2024. Its market cap has decreased by -18.48% in one year.
Market Cap
395.99M
Enterprise Value
963.43M
1-Year Change
-18.48%
Ranking
Category
Stock Price
$7.88
Market Cap Chart
Since June 23, 2022, Enhabit's market cap has decreased from $1.25B to $395.99M, a decrease of -68.26%. That is a compound annual growth rate of -37.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2024 | 395.23M | -23.82% |
| Dec 29, 2023 | 518.84M | -20.54% |
| Dec 30, 2022 | 652.98M | -47.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 403.90M |
| Alpha Teknova | 398.21M |
| ProQR Therapeutics | 396.30M |
| AirSculpt Technologies | 395.34M |
| XOMA Royalty | 394.13M |
| Contineum Therapeutics | 384.35M |
| Delcath Systems | 379.85M |
| Revance Therapeutics | 378.70M |